Potential drug targets in deadly pediatric brain tumors

Researchers studying a rare, always fatal brain tumor in children have found several molecular alterations that drive the cancer, according to a new study. The findings identify potential new targets for drug treatments. The new research could help physicians choose targeted agents with a better chance of combating pediatric high-grade astrocytomas.